Ubs Group Ag Timber Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.1 - $0.3 $461 - $1,384	-4,615 Reduced 9.35%	44,739 $5,000
Q2 2022 Aug 10, 2022	BUY	$0.24 - $0.39 $9,950 - $16,169	41,459 Added 525.13%	49,354 $16,000
Q1 2022 May 16, 2022	SELL	$0.28 - $0.41 $24,230 - $35,479	-86,536 Reduced 91.64%	7,895 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.38 - $0.89 $35,876 - $84,025	94,411 Added 472055.0%	94,431 $36,000
Q2 2021 Aug 13, 2021	SELL	$1.06 - $2.25 $8,881 - $18,852	-8,379 Reduced 99.76%	20 $0
Q1 2021 May 12, 2021	SELL	$0.81 - $3.55 $3,708 - $16,255	-4,579 Reduced 35.28%	8,399 $17,000
Q4 2020 Feb 11, 2021	BUY	$0.72 - $1.52 $6,737 - $14,222	9,357 Added 258.41%	12,978 $10,000
Q3 2020 Nov 12, 2020	SELL	$0.92 - $2.4 $977 - $2,548	-1,062 Reduced 22.68%	3,621 $4,000
Q2 2020 Jul 31, 2020	BUY	$2.16 - $6.95 $10,115 - $32,546	4,683 New	4,683 $10,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.